New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

4.7 (662) · $ 27.00 · In stock

New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

Rapid Development of Neutralizing and Diagnostic SARS-COV-2 Mouse Monoclonal Antibodies

Vaccination with a bacterial peptide conjugated to SARS-CoV-2 receptor-binding domain accelerates immunity and protects against COVID-19 - ScienceDirect

Lipid-Based Poly(I:C) Adjuvants Strongly Enhance the Immunogenicity of SARS-CoV-2 Receptor-Binding Domain Vaccine

Applications of genetic engineering in COVID-19

Targeting SARS-CoV-2 receptor binding domain, as adapted from a source

Frontiers Immunity to SARS-CoV-2: Lessons Learned

COVID-19/SARS-CoV-2 Resources

Applications of genetic engineering in COVID-19 - ScienceDirect

PDF) Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach

Cartoon depicting the interaction between the SARS-CoV-2 trimeric spike

ACE-2 is shown to be the entry receptor for SARS-CoV-2: R&D Systems

© 2018-2024, stofnunsigurbjorns.is, Inc. or its affiliates